Concepedia

Sarah Turcan

ST

Statistics

Publications

2

Citations

256

H-Index

2

Active since

2017

Affiliations

Stanford University(Current)

Washington University in St. Louis

Inserm

Laboratoire d’immunologie intégrative du cancer

Dana-Farber Cancer Institute

Sarah Turcan is an author at Stanford University specializing in tumor microenvironment, antitumor t cell responses, and immunotherapy.

Publications per year

2017–2022

2

Publications

2

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

Nathalie Scholler, Régis Perbost, Frederick L. Locke et al. · Nature Medicine · 2022 · 198 citations · Full text

, , +17

Characterization of anti-CD19 chimeric antigen receptor (CAR) T cell-mediated tumor microenvironment immune gene profile in a multicenter trial (ZUMA-1) with axicabtagene ciloleucel (axi-cel, KTE-C19).

Jérôme Galon, John M. Rossi, Sarah Turcan et al. · Journal of Clinical Oncology · 2017 · 58 citations

, , +17

1–2 of 2